IMV RPE
Quel est le RPE de IMV?
Le RPE de IMV, Inc. est $237.11
Quelle est la définition de RPE?
Le revenu par employé (RPE) est le revenu divisé par le nombre d'employés d'une organisation.
RPE des entreprises dans Health Care secteur sur TSX par rapport à IMV
Que fait IMV?
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
Entreprises avec rpe similaire à IMV
- Premier African Minerals a RPE de $181.82
- GlycoMimetics Inc a RPE de $185.19
- Parabolic Drugs a RPE de ₨197.82
- VirnetX Corp a RPE de $200.00
- Highway a RPE de $201.15
- First Capital a RPE de $205.52
- IMV a RPE de $237.11
- Virnetx Corp a RPE de $300.00
- Sihayo Gold a RPE de AUD$339.97
- BELLUS Health a RPE de $375.00
- BELLUS Health a RPE de $400.00
- Aqua Metals Inc a RPE de $403.23
- Oragenics Inc a RPE de $414.78